These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30722977)

  • 1. Changes in striatal dopamine release and locomotor activity following acute withdrawal from chronic nicotine are mediated by CRF1, but not CRF2, receptors.
    Buzás A; Bokor P; Balangó B; Pintér D; Palotai M; Simon B; Csabafi K; Telegdy G; Szabó G; Bagosi Z
    Brain Res; 2019 Mar; 1706():41-47. PubMed ID: 30722977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of CRF and the urocortins on the hippocampal acetylcholine release in rats.
    Pintér D; Balangó B; Simon B; Palotai M; Csabafi K; Dobó É; Ibos KE; Bagosi Z
    Neuropeptides; 2021 Aug; 88():102147. PubMed ID: 33932861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats.
    Carboni L; Romoli B; Bate ST; Romualdi P; Zoli M
    Drug Alcohol Depend; 2018 Aug; 189():12-20. PubMed ID: 29857328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice.
    Bagosi Z; Palotai M; Simon B; Bokor P; Buzás A; Balangó B; Pintér D; Jászberényi M; Csabafi K; Szabó G
    Brain Res; 2016 Dec; 1652():21-29. PubMed ID: 27693397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.
    Qi X; Guzhva L; Yang Z; Febo M; Shan Z; Wang KKW; Bruijnzeel AW
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1378-1389. PubMed ID: 27461514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
    Bruijnzeel AW; Prado M; Isaac S
    Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of Alcohol Intoxication and Withdrawal on Hypothalamic Neurohormones and Extrahypothalamic Neurotransmitters.
    Simon B; Buzás A; Bokor P; Csabafi K; Ibos KE; Bodnár É; Török L; Földesi I; Siska A; Bagosi Z
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central CRF2 receptor antagonism reduces anxiety states during amphetamine withdrawal.
    Reinbold ED; Scholl JL; Oliver KM; Watt MJ; Forster GL
    Neurosci Res; 2014 Dec; 89():37-43. PubMed ID: 25205625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA; Almeida J; Benini R; Crestani CC
    Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-dependent responses to cocaine depend on corticotropin-releasing factor receptor subtypes.
    Lu L; Liu Z; Huang M; Zhang Z
    J Neurochem; 2003 Mar; 84(6):1378-86. PubMed ID: 12614338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
    Qi X; Shan Z; Ji Y; Guerra V; Alexander JC; Ormerod BK; Bruijnzeel AW
    Transl Psychiatry; 2014 Apr; 4(4):e385. PubMed ID: 24755994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
    Iarushkina NI; Bagaeva TR; Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2014 Nov; 100(11):1287-96. PubMed ID: 25665407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.
    Sekino A; Ohata H; Mano-Otagiri A; Arai K; Shibasaki T
    Psychopharmacology (Berl); 2004 Oct; 176(1):30-8. PubMed ID: 15071721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
    Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
    Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic nicotine treatment and withdrawal on rat striatal D1 and D2 dopamine receptors.
    Kirch DG; Taylor TR; Creese I; Xu SX; Wyatt RJ
    J Pharm Pharmacol; 1992 Feb; 44(2):89-92. PubMed ID: 1352822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
    Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
    Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRF1 and the CRF2 receptor mediate recognition memory deficits and vulnerability induced by opiate withdrawal.
    Morisot N; Contarino A
    Neuropharmacology; 2016 Jun; 105():500-507. PubMed ID: 26907806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.